41
DAFTAR PUSTAKA
1. Chethana E, et all. Endometrial changes in uterine meiomyomas. 2013. Kempegowda Institute of Medical Sciences. J Cin. Biomed Scientifica. Hal : 72 – 79
2. Wachidah, et al. Hubungan hiperplasia endometrium dengan mioma uteri : Studi kasus pada pasien ginekologi RSUD Prof. Dr. Margono Soekardjo. Mandala of Health. 2011.Vol 5, no.3.
3. Baziad A. Endokrinologi Ginekologi. Edisi III. Media Aeusculapius FK UI. Jakarta. 2008. Hal 215 – 222
4. Witherspoon JT. The hormonal origin of uterine fibroids : an hypotesis. Tulane university. Amerika Serikat. 1933.
5. Tim. Ilmu Kandungan. Edisi II. PT. Bina Pustaka Sarwono Prawirohardjo. Jakarta. 2008. Hal : 73 – 90; 338 – 345.
6. Speroff L, Fritz, MA. Clinical gynecologic endocrinology and infertility. edisi VII. Lippincott Williams & Wilkins. North Carolina. 2005. Hal : 136 – 140; 561 – 562
7. Nayak N, et al. Pharmacoepidemiological Study of Uterine Fibroids in Indore City. International Journal of Pharma and Bio Sciences. 2010. Vol.1, no.2.
8. Edward DRV, et al. Association of Age at Menarch with Increasing Number of Fibroids in a Cohort of Women Who Underwent Standardized Ultrasound Assessment. Oxford University Press. 2013. 9. Walker CL, et al. Protektif effect of pegnancy for development of uterine
leiomyoma. Carcinogenesis. Anderson Cancer Center. Smithville. 2001. vol. 22, no.12. Hal 2049 – 52
42
11. Faerstein E, et al. Risk factors for uterine leiomyoma : A Practice – based case control study. I. African – American Heritage, Reproductive History, Body Size, and Smoking. American journal of Epidemiology. Oxford University Press. 2001. Vol. 153, no.1. Hal 1 – 10.
12. Katz, et al. Katz Comprehensive Gynecology : endometrial hyperplasia. Edisi 5. Mosby. USA. 2007.
13. Cunningham, et all. Williams gynecology. Edisi I. McGraw-Hill. China. 2008.
14. Gibs RS, et al. Danforth’s Obstetrics and Gynecologic. Edisi X. Lippincolt Williams and Wilkins. Amerika Serikat. 2008. Hal : 1003 – 6; 917 – 929.
15. DeCherney AH, Nathan L. Current Diagnosis and Treatements in Obstetrics and Gynecology : Benign Disorders of the Uterine Corpus. Edisi X. McGraw-Hill. Amerika Serikat. 2007.
16. Lumsden MA. Dewhurts Text book of Obstetrics and Gynaecology : Benign disease of the uterus. Edisi 7. Blackwell publishing. Massachusetts, 2007. hal 636 – 644.
17. Grings AO, et al. Protein Expression of Estrogen Receptors α and β and Aromatase in Myometrium and Uterine Leiomyoma. 2012. Gynecologic and Obstetric Investigation. No. 73. Hal 113 – 7
18. Hermon TL, et al. Estrogen receptor alpha (ER-α) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to mathed myometrium. 2008. Virchow Arch. No. 453. Hal : 557 - 569
19. Yi Ye, et al. J Assist Reproductive Genetics. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Springer Science. 2008. Vol. 25.
43
21. Mazur MT, Kurman RJ. Diagnosis of endometrial biopsies and curretings : endometrial hyperplasia, endometrial intraepitheal carcinoma, and epithelial cytoplasmic change. Edisi 2. Springer. Amerika serikat. 2005. Hal : 178 – 199.
22. Reed SD, et al. Insidensi of endometrial hyperplasia. Amerika journal obstetric and gynecology. 2009.
23. Pernoll ML. Benson and Pernoll’s handbook of Obstetric and Gynecology. Edisi X. McGraw-Hill. Amerika Serikat. 2001. Hal : 619 – 629.
24. Oehler MK, Rees M. The abnormal menstrual cycle : Excessive menstrual bleeding; Uterine fibroid. Taylor & Francis group. London. 2005. Hal 61 – 70; 79 - 92
25. Childs AJ, et al. Conservative management of endometrial hyperplasia : new strategies and experimental option. Health University Medical Center. 2003. Hal : 15 – 26
26. Olive DL, Palter SF. Berek & Novak’s Gynecology. Edisi 14. Lippincott Williams & Wilkins. California. 2007. Hal : 469 – 471; 1346 – 9.
27. Meniru GI, Hopkins MP. Glass’ office gynecology : abnormal uterine bleeding. Edisi 6. Lippincott Williams and Wilkins. Amerika serikat. 2006. hal : 179 – 181
28. Mutter GL. Endometrial precancer : the benign endometrial hyperplasia squence and EIN. Dept. of pathology brigham and women’s hospital. Harvard medical school. Boston. 2008.
29. Trimble CL, et al. American college of obstetricians and gynecologists : Management of endometrial precancers. Vol. 120, no.5. 2012. 1160 – 1172.
44
31. Walker JL, Zuna RE. Clinical gynecology oncology : Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer. Edisi 7. Mosby Elsevier. Filadelpia. 2007. Hal : 125 – 132.
32. Chu CS. NMS obstetrics and gynecology. Edisi 6. Lippincott Williams and Wilkins. New York. 2008. Hal : 428 – 429; 259 – 266.
33. Chethana M. Histopathologic Study of Endometrium in Uterine Leiomyoma. Dept. Of Pathology Sri Devaraj Urs Medical College. Kolar. 2010.
34. Robboy SJ, et al. Environmental Health Perspectives : Pathology and Pathophysiology of Uterine Smooth-Muscle Tumors. 2000. Vol. 108. 35. Chan CF, et al. Risk factors for uterine fibroids among woman
undergoing tubal sterilization. 2001. A merican Journal of Epidemiology. Vol. 153. No.1. Hal : 20 – 26
36. Ibrar A, et al. Frequency of fibroid uterus in multipara women in a tertiary care centre in Rawalpindi. 2010. J Ayub Med Coll Abbottabad. Vol. 22 No. 3. Hal : 155 – 7
37. Lilyani DV, et al. Hubungan faktor risiko dan kejadian mioma uteri di Rumah Sakit Umum Daerah Tugurejo Semarang. 2012. Jurnal Kedokteran Muhammadiyah. Vol. 1, No.1. Hal : 14 – 19
38. Terry KL et al. Anthropometric Characteristics and Risk of UterineLeiomyoma. Epidemiology. 2007. V.18, No.6. Hal : 758
